COVID kills New Brunswick child aged 0-4
A New Brunswick child aged 0-4 was killed by COVID-19 between March 9-15, according to government data, and influenza killed two people aged 65 or older and one aged 45-64.
The province doesn't provide any information about COVID and flu victims.
Between March 9-15, 10 people were hospitalized with COVID. No one required intensive care.
The province includes data on the number of tests and lab-confirmed cases, but it isn't accurate because it only counts data collected in hospitals.
Forty-five people were hospitalized for influenza between March 9-15, and two people required intensive care.
There were 11 lab-confirmed flu outbreaks, including seven in nursing homes and four in undisclosed facilities. There was also one outbreak of an influenza-like illness in a school.
Finally, there were 66 confirmed cases of RSV between March 9-15. Three people required hospital treatment.
Some New Brunswickers will soon be able to get a new COVID-19 vaccination, the government announced on Monday, but it doesn't appear the shots will be available to most.
The eligible groups are, according to a government press release, 'people aged 65 or older, adult residents of long-term care homes and other congregate-living settings for seniors,' and 'people six months or older who are moderately to severely immunocompromised due to underlying conditions or treatment.'
The release doesn't explain why the vaccine isn't available to everyone, other than a note saying the province is following 'updated guidance from the National Advisory Committee on Immunization.'
Shots will be available from April 7 to June 30, and will be administered by 'participating pharmacies,' the release read. However for children under 12, the shots will only be available until June 21 because 'vaccine products for this age group are expiring and additional vaccines will not be immediately available.'
'Getting vaccinated is one of the best ways to help protect yourself and your community against the impact of vaccine-preventable diseases and illnesses, including COVID-19,' chief medical health officer Dr. Yves Léger said in the release.
'Vaccines against COVID-19 are very effective at preventing severe disease in the elderly and those who are at higher risk. However, studies show that this protection does drop after many months, which is why getting a spring dose is important for those groups.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Hamden school raises money for cancer research at ‘Saint Baldrick's' event
HAMDEN, Conn. (WTNH) — Saint Rita School in Hamden school raised money for cancer research, participating in the 'Saint Baldrick's' event. Multiple people volunteered to shave their heads. Students, faculty and staff also used the event to recognize childhood cancer survivors, including seventh-grade student Juliette Walsh. Southington brewery hosts 'Let's Get Buzzed' fundraiser for kids battling cancer 'They're really supportive and there's always people looking out for you,' Walsh said 'I was 8 and it was hard because it was during COVID but there were always a lot of people there to help you.' Saint Rita School said this was the fourth time they have surpassed their fundraising goal. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
an hour ago
- Yahoo
RFK Jr. fires CDC's independent vaccine advisors
Health and Human Services Secretary Robert F. Kennedy Jr. said he is removing every member of the independent panel advising the Centers for Disease Control and Prevention on vaccines, an unprecedented escalation in his quest to reshape the agency. In a Wall Street Journal op-ed released Monday, Kennedy said the move was necessary to restore faith in vaccines. 'A clean sweep is needed to re-establish public confidence in vaccine science,' Kennedy wrote. 'The public must know that unbiased science—evaluated through a transparent process and insulated from conflicts of interest—guides the recommendations of our health agencies,' Kennedy said in a subsequent statement. Kennedy said removing every member of the panel will give the Trump administration an opportunity to appoint its own members. Kennedy has long accused ACIP members of having conflicts of interest, sparking concern among vaccine advocates that he would seek to install members who are far more skeptical of approving new vaccines. 'The prior administration made a concerted effort to lock in public health ideology and limit the incoming administration's ability to take the proper actions to restore public trust in vaccines,' Kennedy said. The panelists are not political appointees. The ACIP meets three times a year to review data on vaccines and recommend how they should be used. It is comprised of independent medical and public health experts who do not work for CDC. Members are appointed to four-year terms The panel recently considered narrowing the recommendations for COVID-19 vaccinations for children and was next scheduled to meet later this month to review and vote on recommendations. The HHS statement indicated the meeting will continue as scheduled at CDC's Atlanta headquarters. Ahead of Kennedy's Senate confirmation vote, Sen. Bill Cassidy (R-La.) said Kennedy pledged to maintain the panel 'without changes.' In a post on X, Cassidy said he had just spoken with Kennedy about the move. 'Of course, now the fear is that the ACIP will be filled up with people who know nothing about vaccines except suspicion,' he said. 'I've just spoken with Secretary Kennedy, and I'll continue to talk with him to ensure this is not the case.' Cassidy declined to answer additional questions Monday evening when asked by reporters. Senate Minority Leader Chuck Schumer (D-N.Y.) said Kennedy and the Trump administration are 'taking a wrecking ball' to health and safety programs. 'Firing experts that have spent their entire lives protecting kids from deadly disease is not reform — it's reckless, radical, and rooted in conspiracy, not science,' Schumer said in a statement. 'Wiping out an entire panel of vaccine experts doesn't build trust — it shatters it, and worse, it sends a chilling message: that ideology matters more than evidence, and politics more than public health.' Updated at 7:20 p.m. EDT Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Chicago Tribune
2 hours ago
- Chicago Tribune
Used in COVID shots, mRNA may help rid the body of HIV
The technology that powered COVID vaccines may also lead scientists to a cure for HIV. Using mRNA, Australian researchers said they were able to trick the virus to come out of hiding, a crucial step in ridding the body of it entirely. The research, published last week in Nature Communications, is still preliminary and so far has been shown to be successful only in a lab. But it suggests that mRNA has potential far beyond its use in vaccines as a means to deliver therapies against stubborn adversaries. Short for messenger RNA, mRNA is a set of instructions for a gene. In the case of COVID vaccines, the instructions were for a piece of the coronavirus. In the new study, they are for molecules key to targeting HIV. Dr. Sharon Lewin, director of the Doherty Institute at the University of Melbourne, who led the study, called mRNA a 'miraculous' tool 'to deliver things that you want into places that were not possible before.' Vaccines deploying mRNA instruct the body to produce a fragment of the virus, which then sets off the body's immune response. In the United States, the shots were initially hailed for turning back the pandemic, then viewed by some with suspicion and fear. Some officials, including Health Secretary Robert F. Kennedy Jr., have falsely said that they are highly dangerous and even deadly. Last week, the Department of Health and Human Services sought to limit the vaccine's availability to pregnant women, children and healthy younger adults. The administration also canceled a nearly $600 million contract with the drugmaker Moderna to develop an mRNA shot for humans against bird flu. 'The fear right now is not rational,' Lewin said, adding that 'mRNA vaccines have been given to millions of people around the world, so we have a very good understanding of their risks.' The new study describes the use of mRNA as a tool to flush HIV out of its hiding places. Other uses could involve providing proteins missing from those with certain diseases or correcting genetic errors. Frauke Muecksch, a virologist at Heidelberg University in Germany who was not involved in the work, called mRNA a 'promising, absolutely powerful technology.' Although most people may have only heard of mRNA's use in science during the pandemic, scientists have been working with it for more than 20 years, she said. 'I think it's not just therapeutically very powerful, but also for basic science, for research, it opens up a lot of avenues,' she added. Potent antiretroviral drugs can now control HIV, suppressing it to undetectable levels. Still, minute amounts of the virus lie dormant in so-called reservoirs, waiting for an opportunity to resurge. A cure for HIV would involve ferreting out all of this virus and destroying it, a strategy that has been called 'shock and kill.' A significant hurdle is that the virus lies dormant in a particular type of immune cell, called a resting CD4 cell. Because these cells are inactive, they tend to be unresponsive to drugs. The few drugs scientists have previously used to rouse the virus in these cells were not specific to HIV and had unwanted side effects. 'It's fair to say the field's been a little bit stuck,' said Brad Jones, a viral immunologist at Weill Cornell Medicine who was not involved in the latest research. In 2022, Jones and his colleagues found that the immune boost from the mRNA vaccines awakened latent HIV in people living with the virus. (Other research has shown that mRNA vaccines also activated dormant viruses including Epstein Barr.) 'You get just a little bit of a gentle nudge with some of these vaccines, and it's enough to coax some of these latent viruses out so they can be killed,' Jones said. Lewin and her colleagues had for years experimented with other ways to activate HIV but had no luck in resting cells. Seeing the success of the COVID vaccines, which used lipid nanoparticles — tiny spheres of fat — containing mRNA, her team tested similar particles. They used the particles to deliver two different sets of molecules: Tat, which is adept at switching HIV on, and CRISPR, a tool that can 'edit' genes. The researchers showed that in resting immune cells from people living with HIV, the approach coaxed the virus out of dormancy. 'It's very, very hard to deal with these cells, so I think this really targeting the right population of cells is what makes this paper special,' Muecksch said. It's unclear whether the new approach can successfully awaken all of the dormant HIV in the body, and what side effects it might produce. Lewin said that 'mRNA will almost certainly have some adverse effects, as every drug does, but we will investigate that systematically, as we do for any new drug.' In this case, she said, side effects may be more acceptable to people living with HIV than having to take medications for the rest of their lives. The researchers plan to test the method in HIV-infected animals next, before moving into clinical trials. This article originally appeared in The New York Times.
